StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.21+0.01 (+6.06%)

Close on Nov 17, 2026Market cap $947.51KP/E –Yield –

Oragenics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Oragenics's price to sales ratio was 461.1× on Oct 31, 2012, against 440.3× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2012Oct 31, 2012461.1×+328.7
2011Dec 30, 2011132.3×–

More Oragenics figures

See a number that looks wrong?